Table 2. Patient characteristics and outcomes of C-EMR.

Patient no.	Morphology	Location	Size (mm)	Polypectomy technique	Adjunct techniques	Histology	Follow-up (months)
1	Sessile	Lip of ICV	15	Piecemeal	APC	TA	25
2	Sessile	Lip of ICV	10	En bloc	None	Adenocarcinoma	2
3	Sessile	Lip of ICV	20	Piecemeal	APC/snare	TVA	Patient declined
4	Flat	Lip of ICV	6	En bloc	None	TA	5
5	Flat	Lip of ICV	15	Piecemeal	None	TVA	Lost to follow up
6	Sessile	Invading into terminal ileum	25	Piecemeal	None	TA	3
7	Flat	Lip of ICV	20	Piecemeal	APC	TVA	6
8	Flat	Invading into cecum	20	Piecemeal	APC/snare	SSA	4, 67
9	Flat	Lip of ICV	15	Piecemeal	Snare	Inflammatory	36
10	Flat	Invading into cecum	20	En bloc	None	TA	4
11	Sessile	Invading into cecum	15	Piecemeal	APC	TVA	3
12	Flat	Invading into cecum	35	Piecemeal	Snare	TVA	3, 8
13	Sessile	Invading into cecum	15	En bloc	None	TA	3, 56
14	Flat	Lip of ICV	10	Piecemeal	APC/snare	TA	7
15	Flat	Lip of ICV	10	En bloc	Coagulation grasper for visible vessels	TA	NI
16	Flat	Invading into cecum	45	Piecemeal	Coagulation grasper for visible vessels	TVA with areas approaching high grade dysplasia	Declined follow up given terminal diagnosis of liver cancer
17	Flat	Lip of ICV	15	En bloc	Snare	TA	NI
18	Flat	Lip of ICV	20	Piecemeal	None	SSA	8
19	Flat	Lip of ICV	20	Piecemeal	Hemoclips to prevent bleeding	TA	7
20	Flat	Lip of ICV	5	En bloc	None	Lipoma	NI
21	Sessile	Lip of ICV	10	Piecemeal	APC	TVA	7

C-EMR, cap-assisted endoscopic mucosal resection; ICV, ileocecal valve; APC, argon plasma coagulation; TA, tubular adenoma; TVA, tubulovillous adenoma; SSA, sessile serrated adenoma; NA, not available; NI, not indicated.